P
PharmaResearch Co Ltd
KOSDAQ:214450
PharmaResearch Co Ltd
KOSDAQ:214450
Price:
198 400
KRW
-0.8%
Market Closed
Market Cap:
2.1T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
PharmaResearch Co Ltd
198400
-1600 (-0.8%)
| 52 Week Range |
89 100
235 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
PharmaResearch Co Ltd
Income Statement
Earnings Waterfall
PharmaResearch Co Ltd
PharmaResearch Co Ltd
|
Revenue
|
296.6B
KRW
|
|
Cost of Revenue
|
-85.6B
KRW
|
|
Gross Profit
|
211B
KRW
|
|
Operating Expenses
|
-108.8B
KRW
|
|
Operating Income
|
102.2B
KRW
|
|
Other Expenses
|
-11.4B
KRW
|
|
Net Income
|
90.7B
KRW
|
Income Statement
PharmaResearch Co Ltd
PharmaResearch Co Ltd
Currency: KRW
| Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||
| Revenue |
24 765
N/A
|
28 237
+14%
|
31 577
+12%
|
34 543
+9%
|
37 455
+8%
|
40 854
+9%
|
43 810
+7%
|
45 094
+3%
|
45 953
+2%
|
46 580
+1%
|
47 240
+1%
|
50 614
+7%
|
54 470
+8%
|
56 518
+4%
|
60 777
+8%
|
61 865
+2%
|
64 281
+4%
|
70 242
+9%
|
73 324
+4%
|
77 416
+6%
|
83 872
+8%
|
84 091
+0%
|
91 747
+9%
|
101 283
+10%
|
108 746
+7%
|
122 609
+13%
|
133 706
+9%
|
143 282
+7%
|
154 083
+8%
|
164 813
+7%
|
175 719
+7%
|
183 191
+4%
|
194 759
+6%
|
204 932
+5%
|
222 030
+8%
|
244 661
+10%
|
261 011
+7%
|
280 285
+7%
|
296 594
+6%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(6 555)
|
(7 830)
|
(9 611)
|
(10 579)
|
(11 687)
|
(12 644)
|
(12 999)
|
(14 187)
|
(15 116)
|
(15 612)
|
(16 131)
|
(17 038)
|
(18 405)
|
(19 216)
|
(21 862)
|
(23 409)
|
(26 064)
|
(28 623)
|
(30 954)
|
(33 140)
|
(33 766)
|
(33 603)
|
(34 271)
|
(35 024)
|
(35 850)
|
(38 538)
|
(40 183)
|
(42 495)
|
(45 750)
|
(49 113)
|
(51 440)
|
(52 202)
|
(53 246)
|
(54 915)
|
(58 063)
|
(63 915)
|
(70 753)
|
(78 668)
|
(85 590)
|
|
| Gross Profit |
18 210
N/A
|
20 408
+12%
|
21 967
+8%
|
23 965
+9%
|
25 768
+8%
|
28 210
+9%
|
30 811
+9%
|
30 907
+0%
|
30 837
0%
|
30 968
+0%
|
31 109
+0%
|
33 577
+8%
|
36 065
+7%
|
37 303
+3%
|
38 916
+4%
|
38 456
-1%
|
38 217
-1%
|
41 620
+9%
|
42 371
+2%
|
44 277
+4%
|
50 106
+13%
|
50 488
+1%
|
57 476
+14%
|
66 258
+15%
|
72 896
+10%
|
84 070
+15%
|
93 522
+11%
|
100 787
+8%
|
108 333
+7%
|
115 701
+7%
|
124 280
+7%
|
130 989
+5%
|
141 513
+8%
|
150 018
+6%
|
163 967
+9%
|
180 746
+10%
|
190 258
+5%
|
201 617
+6%
|
211 004
+5%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(6 796)
|
(7 045)
|
(7 944)
|
(8 201)
|
(9 674)
|
(12 377)
|
(13 960)
|
(14 210)
|
(16 732)
|
(15 272)
|
(15 728)
|
(17 083)
|
(21 222)
|
(24 021)
|
(26 780)
|
(30 758)
|
(29 512)
|
(33 589)
|
(30 956)
|
(30 620)
|
(31 044)
|
(31 783)
|
(34 868)
|
(37 797)
|
(39 470)
|
(44 155)
|
(47 738)
|
(50 830)
|
(55 844)
|
(61 109)
|
(66 208)
|
(70 050)
|
(75 597)
|
(83 708)
|
(91 402)
|
(97 204)
|
(98 001)
|
(106 550)
|
(108 823)
|
|
| Selling, General & Administrative |
(4 671)
|
(4 817)
|
(5 883)
|
(6 252)
|
(7 439)
|
(9 862)
|
(10 874)
|
(11 369)
|
(12 844)
|
(11 302)
|
(10 914)
|
(11 366)
|
(16 127)
|
(17 283)
|
(20 435)
|
(23 398)
|
(21 213)
|
(22 809)
|
(21 449)
|
(20 827)
|
(20 536)
|
(21 379)
|
(24 260)
|
(26 711)
|
(28 535)
|
(31 034)
|
(33 691)
|
(36 760)
|
(42 762)
|
(46 882)
|
(51 123)
|
(53 941)
|
(59 651)
|
(61 367)
|
(67 182)
|
(71 841)
|
(75 095)
|
(79 359)
|
(80 270)
|
|
| Research & Development |
(1 899)
|
(1 624)
|
(1 615)
|
(1 569)
|
(1 763)
|
(2 013)
|
(2 578)
|
(2 309)
|
(3 378)
|
(3 447)
|
(4 269)
|
(5 150)
|
(4 497)
|
(5 206)
|
(4 529)
|
(4 379)
|
(4 043)
|
(4 177)
|
(4 368)
|
(4 824)
|
(5 614)
|
(5 569)
|
(5 386)
|
(5 673)
|
(5 543)
|
(6 167)
|
(6 793)
|
(6 581)
|
(6 738)
|
(7 002)
|
(7 578)
|
(8 305)
|
(8 702)
|
(9 706)
|
(11 481)
|
(12 506)
|
(15 030)
|
(16 189)
|
(17 727)
|
|
| Depreciation & Amortization |
(226)
|
(575)
|
(417)
|
(351)
|
(471)
|
(497)
|
(504)
|
(529)
|
(510)
|
(523)
|
(543)
|
(566)
|
(597)
|
(649)
|
(1 815)
|
(2 980)
|
(4 257)
|
(5 570)
|
(5 143)
|
(4 973)
|
(4 894)
|
(4 837)
|
(5 224)
|
(5 414)
|
(5 392)
|
(5 704)
|
(6 009)
|
(6 244)
|
(6 344)
|
(6 385)
|
(6 715)
|
(7 013)
|
(7 384)
|
(7 711)
|
(7 767)
|
(7 885)
|
(8 003)
|
(8 171)
|
(8 222)
|
|
| Other Operating Expenses |
0
|
(29)
|
(29)
|
(29)
|
0
|
(5)
|
(4)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
(883)
|
0
|
0
|
0
|
(1 033)
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
(1 250)
|
(1 245)
|
(1 245)
|
0
|
(840)
|
(792)
|
(792)
|
140
|
(4 924)
|
(4 972)
|
(4 972)
|
128
|
(2 831)
|
(2 605)
|
|
| Operating Income |
11 414
N/A
|
13 361
+17%
|
14 022
+5%
|
15 763
+12%
|
16 094
+2%
|
15 833
-2%
|
16 850
+6%
|
16 696
-1%
|
14 105
-16%
|
15 695
+11%
|
15 382
-2%
|
16 494
+7%
|
14 843
-10%
|
13 283
-11%
|
12 136
-9%
|
7 699
-37%
|
8 705
+13%
|
8 030
-8%
|
11 414
+42%
|
13 656
+20%
|
19 062
+40%
|
18 706
-2%
|
22 609
+21%
|
28 463
+26%
|
33 426
+17%
|
39 917
+19%
|
45 786
+15%
|
49 958
+9%
|
52 489
+5%
|
54 592
+4%
|
58 071
+6%
|
60 939
+5%
|
65 916
+8%
|
66 309
+1%
|
72 565
+9%
|
83 541
+15%
|
92 258
+10%
|
95 067
+3%
|
102 181
+7%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(304)
|
(330)
|
(453)
|
(132)
|
168
|
1 813
|
3 455
|
4 165
|
3 308
|
2 250
|
1 740
|
1 319
|
1 861
|
2 100
|
3 204
|
2 874
|
650
|
1 232
|
(1 359)
|
(918)
|
73
|
(154)
|
(81)
|
(866)
|
3 382
|
3 146
|
3 848
|
5 993
|
4 030
|
2 555
|
(2 426)
|
(1 314)
|
(6 668)
|
(3 937)
|
960
|
4 686
|
12 355
|
7 014
|
13 792
|
|
| Non-Reccuring Items |
(29)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(881)
|
0
|
(1 917)
|
(1 917)
|
(868)
|
0
|
0
|
0
|
67
|
0
|
(6)
|
(6)
|
(1 251)
|
0
|
0
|
0
|
(840)
|
0
|
0
|
0
|
(5 111)
|
0
|
0
|
0
|
(3 120)
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(16)
|
(5)
|
(5)
|
(5)
|
(1)
|
(4)
|
(7)
|
(49)
|
(60)
|
(87)
|
(89)
|
(59)
|
(84)
|
0
|
(187)
|
(396)
|
(495)
|
0
|
(513)
|
(473)
|
(325)
|
0
|
0
|
(231)
|
(363)
|
0
|
0
|
0
|
230
|
254
|
290
|
245
|
(114)
|
(88)
|
(127)
|
(83)
|
36
|
(6)
|
(1)
|
|
| Total Other Income |
25
|
21
|
(49)
|
(42)
|
(73)
|
(95)
|
(92)
|
(92)
|
(28)
|
(17)
|
(327)
|
(328)
|
(344)
|
(405)
|
(607)
|
(708)
|
6 373
|
5 430
|
6 481
|
6 662
|
(348)
|
(277)
|
4 443
|
4 432
|
4 343
|
4 256
|
(290)
|
88
|
124
|
22
|
64
|
2
|
25
|
71
|
(643)
|
(561)
|
(825)
|
(938)
|
(155)
|
|
| Pre-Tax Income |
11 091
N/A
|
13 047
+18%
|
13 516
+4%
|
15 585
+15%
|
16 185
+4%
|
17 547
+8%
|
20 205
+15%
|
20 719
+3%
|
17 325
-16%
|
17 842
+3%
|
16 706
-6%
|
17 426
+4%
|
15 396
-12%
|
14 978
-3%
|
12 628
-16%
|
7 551
-40%
|
14 364
+90%
|
14 692
+2%
|
16 023
+9%
|
18 927
+18%
|
18 529
-2%
|
18 275
-1%
|
26 965
+48%
|
31 791
+18%
|
39 537
+24%
|
47 319
+20%
|
49 345
+4%
|
56 038
+14%
|
56 033
0%
|
57 423
+2%
|
55 999
-2%
|
59 872
+7%
|
54 048
-10%
|
62 356
+15%
|
72 754
+17%
|
87 583
+20%
|
100 705
+15%
|
101 137
+0%
|
115 817
+15%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(2 254)
|
(2 633)
|
(2 884)
|
(3 277)
|
(3 308)
|
(3 553)
|
(3 830)
|
(4 056)
|
(3 498)
|
(3 613)
|
(3 478)
|
(3 219)
|
(2 879)
|
(2 795)
|
(2 955)
|
(2 840)
|
(3 099)
|
(3 285)
|
(2 726)
|
(2 697)
|
(3 678)
|
(3 604)
|
(5 787)
|
(6 579)
|
(7 085)
|
(6 697)
|
(6 511)
|
(7 152)
|
(9 210)
|
(13 088)
|
(13 642)
|
(14 193)
|
(10 614)
|
(10 446)
|
(15 440)
|
(18 683)
|
(23 440)
|
(23 895)
|
(25 039)
|
|
| Income from Continuing Operations |
8 838
|
10 414
|
10 631
|
12 307
|
12 878
|
13 993
|
16 375
|
16 664
|
13 827
|
14 229
|
13 228
|
14 206
|
12 517
|
12 183
|
9 673
|
4 711
|
11 265
|
11 406
|
13 296
|
16 229
|
14 851
|
14 671
|
21 178
|
25 212
|
32 452
|
40 623
|
42 834
|
48 886
|
46 824
|
44 335
|
42 357
|
45 680
|
43 434
|
51 910
|
57 314
|
68 900
|
77 265
|
77 243
|
90 778
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
60
|
82
|
149
|
245
|
317
|
439
|
397
|
1 463
|
2 203
|
3 143
|
3 904
|
3 087
|
2 831
|
1 817
|
1 736
|
1 930
|
1 790
|
322
|
(470)
|
(1 300)
|
(1 775)
|
(135)
|
(583)
|
9
|
821
|
(2 857)
|
(2 946)
|
(1 699)
|
(3 998)
|
(713)
|
(1 151)
|
(34)
|
|
| Net Income (Common) |
8 836
N/A
|
10 413
+18%
|
10 629
+2%
|
12 305
+16%
|
12 878
+5%
|
13 993
+9%
|
16 375
+17%
|
16 725
+2%
|
13 909
-17%
|
14 378
+3%
|
13 473
-6%
|
14 523
+8%
|
12 956
-11%
|
12 580
-3%
|
11 135
-11%
|
6 914
-38%
|
14 408
+108%
|
15 311
+6%
|
16 385
+7%
|
19 061
+16%
|
16 667
-13%
|
16 408
-2%
|
23 109
+41%
|
27 003
+17%
|
32 774
+21%
|
40 152
+23%
|
41 533
+3%
|
47 109
+13%
|
46 689
-1%
|
43 752
-6%
|
42 366
-3%
|
46 501
+10%
|
40 577
-13%
|
48 964
+21%
|
55 615
+14%
|
64 902
+17%
|
76 551
+18%
|
76 092
-1%
|
90 744
+19%
|
|
| EPS (Diluted) |
1 262.28
N/A
|
1 487.57
+18%
|
1 518.42
+2%
|
1 757.85
+16%
|
1 609.75
-8%
|
1 554.77
-3%
|
1 819.44
+17%
|
1 858.33
+2%
|
1 545.44
-17%
|
1 597.55
+3%
|
1 497
-6%
|
1 613.66
+8%
|
1 439.55
-11%
|
1 258
-13%
|
1 237.22
-2%
|
768.22
-38%
|
1 440.8
+88%
|
1 531.1
+6%
|
1 820.55
+19%
|
2 117.88
+16%
|
1 851.88
-13%
|
1 823.11
-2%
|
2 310.9
+27%
|
2 700.3
+17%
|
3 277.4
+21%
|
4 063.45
+24%
|
4 163.31
+2%
|
4 722.28
+13%
|
4 644.41
-2%
|
4 149.42
-11%
|
4 018
-3%
|
4 410.17
+10%
|
3 848.31
-13%
|
4 638.18
+21%
|
5 236.01
+13%
|
6 155.34
+18%
|
7 249.68
+18%
|
7 205.61
-1%
|
8 593.11
+19%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
